Dario Lehoux

1.1k total citations
36 papers, 784 citations indexed

About

Dario Lehoux is a scholar working on Molecular Biology, Infectious Diseases and Surgery. According to data from OpenAlex, Dario Lehoux has authored 36 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Dario Lehoux's work include Bacterial Genetics and Biotechnology (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Dario Lehoux is often cited by papers focused on Bacterial Genetics and Biotechnology (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Dario Lehoux collaborates with scholars based in United States, Canada and China. Dario Lehoux's co-authors include Roger C. Lévesque, François Sanschagrin, Éric Potvin, Irena Kukavica‐Ibrulj, Gee W. Lau, Karine L. Richard, Adel Rafai Far, Greg Moeck, Thomas Parr and Francis F. Arhin and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Dario Lehoux

36 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dario Lehoux United States 16 366 187 182 114 109 36 784
Karen E. Kempsell United Kingdom 15 374 1.0× 164 0.9× 141 0.8× 333 2.9× 90 0.8× 22 951
Dayle A. Daines United States 18 380 1.0× 186 1.0× 98 0.5× 66 0.6× 147 1.3× 32 827
Sophie Moreau‐Marquis United States 11 712 1.9× 121 0.6× 230 1.3× 43 0.4× 70 0.6× 14 1.2k
Marion Sparrius Netherlands 14 342 0.9× 195 1.0× 192 1.1× 330 2.9× 94 0.9× 18 946
Yannick Rossez France 15 373 1.0× 108 0.6× 52 0.3× 60 0.5× 89 0.8× 32 744
Karen Moreau France 18 933 2.5× 280 1.5× 112 0.6× 297 2.6× 114 1.0× 43 1.4k
Slade A. Loutet Canada 16 381 1.0× 104 0.6× 186 1.0× 31 0.3× 69 0.6× 23 877
Stéphanie Bury‐Moné France 15 398 1.1× 224 1.2× 54 0.3× 102 0.9× 103 0.9× 28 911
Matthew A. Crawford United States 14 246 0.7× 117 0.6× 88 0.5× 102 0.9× 56 0.5× 23 596
M. Callaghan Ireland 20 467 1.3× 74 0.4× 135 0.7× 51 0.4× 53 0.5× 30 971

Countries citing papers authored by Dario Lehoux

Since Specialization
Citations

This map shows the geographic impact of Dario Lehoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Lehoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Lehoux more than expected).

Fields of papers citing papers by Dario Lehoux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Lehoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Lehoux. The network helps show where Dario Lehoux may publish in the future.

Co-authorship network of co-authors of Dario Lehoux

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Lehoux. A scholar is included among the top collaborators of Dario Lehoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Lehoux. Dario Lehoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Swift, Steven M., Xavier Vila‐Farrés, Wessam Abdelhady, et al.. (2024). The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia. The Journal of Infectious Diseases. 230(2). 309–318. 3 indexed citations
2.
Lehoux, Dario, David Kallend, Peter Wijngaard, Alan Brown, & Brad Zerler. (2023). The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions. Pharmacology Research & Perspectives. 11(2). e01080–e01080. 2 indexed citations
3.
Karau, Melissa J., Suzannah M. Schmidt-Malan, Jay Mandrekar, et al.. (2022). Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistantStaphylococcus aureusimplant-associated osteomyelitis. Journal of Bone and Joint Infection. 7(4). 169–175. 8 indexed citations
4.
Lehoux, Dario, Adel Rafai Far, David Kallend, Peter Wijngaard, & Brad Zerler. (2022). Evaluation of the distribution and excretion of [14C]-inclisiran following single subcutaneous administration in cynomolgus monkeys. Toxicology and Applied Pharmacology. 443. 115978–115978. 6 indexed citations
5.
Asempa, Tomefa E., et al.. (2021). Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model. Journal of Antimicrobial Chemotherapy. 76(10). 2622–2628. 4 indexed citations
6.
Kebriaei, Razieh, Kyle Stamper, Katherine L. Lev, et al.. (2021). Exebacase in Addition to Daptomycin against MRSA. Antimicrobial Agents and Chemotherapy. 65(11). e0012821–e0012821. 7 indexed citations
7.
Xiong, Yan Q., Wessam Abdelhady, Youngju Pak, et al.. (2020). Effect of the Lysin Exebacase on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus Endocarditis as Determined by Echocardiography. Antimicrobial Agents and Chemotherapy. 64(7). 14 indexed citations
8.
Karau, Melissa J., Suzannah M. Schmidt-Malan, Qun Yan, et al.. (2019). Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats. Antimicrobial Agents and Chemotherapy. 63(10). 24 indexed citations
9.
Lehoux, Dario, et al.. (2015). Oritavancin Pharmacokinetics and Bone Penetration in Rabbits. Antimicrobial Agents and Chemotherapy. 59(10). 6501–6505. 29 indexed citations
10.
Bellibas, S. Eralp, Runlin Gao, Dario Lehoux, et al.. (2014). GW25-e0874 Pharmacokinetics and Pharmacodynamics of Bivalirudin (Angiomax ® ) in Chinese Patients Undergoing PCI. Journal of the American College of Cardiology. 64(16). C144–C145. 1 indexed citations
11.
Lehoux, Dario. (2008). Efficacy of Oritavancin (ORI) in the Mouse Bacteremia Model. 46th Annual Meeting. 1 indexed citations
12.
Lehoux, Dario. (2008). Efficacy of Oritavancin Against Clostridium difficile (CD) Infection in the Hamster Model of CD Infection (CDI). 46th Annual Meeting. 3 indexed citations
13.
Dietrich, Evelyne, Tom J. Houghton, Francis F. Arhin, et al.. (2008). Bisphosphonated Benzoxazinorifamycin Prodrugs for the Prevention and Treatment of Osteomyelitis. ChemMedChem. 3(12). 1863–1868. 21 indexed citations
14.
Ciblat, Stéphane, Adam Belley, Evelyne Dietrich, et al.. (2005). Novel non-nucleobase inhibitors of Staphylococcus aureus DNA polymerase IIIC. Bioorganic & Medicinal Chemistry Letters. 16(4). 891–896. 17 indexed citations
15.
Lehoux, Dario, François Sanschagrin, Irena Kukavica‐Ibrulj, Éric Potvin, & Roger C. Lévesque. (2004). Identification of Novel Pathogenicity Genes by PCR Signature-Tagged Mutagenesis and Related Technologies. Humana Press eBooks. 266. 289–304. 9 indexed citations
16.
Potvin, Éric, Dario Lehoux, Irena Kukavica‐Ibrulj, et al.. (2003). In vivo functional genomics of Pseudomonas aeruginosa for high‐throughput screening of new virulence factors and antibacterial targets. Environmental Microbiology. 5(12). 1294–1308. 155 indexed citations
17.
Lehoux, Dario & Roger C. Lévesque. (2003). PCR Screening in Signature-Tagged Mutagenesis of Essential Genes. Humana Press eBooks. 192. 225–234. 3 indexed citations
18.
Lehoux, Dario, et al.. (2002). Identification of in vivo essential genes fromPseudomonas aeruginosaby PCR-based signature-tagged mutagenesis. FEMS Microbiology Letters. 210(1). 73–80. 24 indexed citations
19.
Lehoux, Dario & Roger C. Lévesque. (2000). Detection of genes essential in specific niches by signature-tagged mutagenesis. Current Opinion in Biotechnology. 11(5). 434–439. 22 indexed citations
20.
Lehoux, Dario, et al.. (2000). Genomics of the 35-kbpvdlocus and analysis of novelpvdIJKgenes implicated in pyoverdine biosynthesis inPseudomonas aeruginosa. FEMS Microbiology Letters. 190(1). 141–146. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karen E. Kempsell Breakdown of academic impact, for papers by Dayle A. Daines Breakdown of academic impact, for papers by Sophie Moreau‐Marquis Breakdown of academic impact, for papers by Marion Sparrius Breakdown of academic impact, for papers by Yannick Rossez Breakdown of academic impact, for papers by Karen Moreau Breakdown of academic impact, for papers by Slade A. Loutet Breakdown of academic impact, for papers by Stéphanie Bury‐Moné Breakdown of academic impact, for papers by Matthew A. Crawford Breakdown of academic impact, for papers by M. Callaghan
Rankless by CCL
2026